Literature DB >> 385186

Hepatitis B core antigen immune complexes in the liver of hepatitis B patients.

M B Ray, V J Desmet, A F Bradburne, J Desmyter, J Fevery, J De Groote.   

Abstract

Single liver biopsies from 102 clinically diagnosed hepatitis patients were examined by immunofluorescence for the presence of hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg), complement and immunoglobulin deposition, and for their capacity to fix human complement in vitro. Of the sixty-five HBsAg positive livers, fifty-three were histologically diagnosed as chronic hepatitis, three as acute hepatitis, five as acute hepatitis with signs of transition to chronicity, and four as 'near normal liver'. In the group with chronic hepatitis, HGcAg was observed in thirty-nine livers, all of which also had HBsAg. Thirty-five of these thirty-nine cases also had the ability to fix complement in vitro in the hepatocyte nuclei and/or cytoplasm. Of these thirty-five cases, twenty-nine were positive for immunoglobulin deposition on the nuclei. All of these cases had antibody to HBcAg in the blood, but only five had anti-HBs. The frequency of in vitro complement fixation and immunoglobulin deposition was higher in active forms of the disease, such as chronic aggressive hepatitis and active cirrhosis, than in non-active disease such as chronic persistent hepatitis and mild cirrhosis. By the application of double fluorescent staining techniques, complement fixation was observed in some HBcAg-positive nuclei. In the 'near normal liver' cases there was no intrahepatic accumulation of HBcAg, and despite the presence of anti-HBc in the blood, in vitro complement fixation and immunoglobulin deposition were both absent. The group of three HBsAg ositive 'acute hepatitis with signs of transition to chronicity' cases behaved similarly to those with chronic aggressive hepatitis and had circulating anti-HBc, in vitro complement fixation and immunoglobulin deposition in the hepatocytes. None had circulating anti-HBs. In the group sith HBs-positive acute hepatitis, anti-HGc in the blood was the only other evidence of hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385186      PMCID: PMC1537663     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Localisation of e-antigen in nuclei of hepatocytes in HBsAg-positive liver diseases.

Authors:  W Arnold; J O Nielsen; F Hardt; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

4.  Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.

Authors:  A A Laiwah; A K Chaudhuri; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

5.  Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver biopsies of hepatitis B patients.

Authors:  M B Ray; V J Desmet
Journal:  Acta Gastroenterol Belg       Date:  1976 Sep-Oct       Impact factor: 1.316

6.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

7.  New antigen-antibody system in Australia-antigen-positive hepatitis.

Authors:  J D Almeida; D Rubenstein; E J Stott
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

8.  Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease.

Authors:  M Rizzetto; F Bonino; O Crivelli; M G Canese; G Verme
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

9.  Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

Authors:  I L Woolf; N El Sheikh; H Cullens; W M Lee; A L Eddleston; R Williams; A J Zuckerman
Journal:  Br Med J       Date:  1976-09-18

10.  Hepatitis B core antigen: immunology and electron microscopy.

Authors:  L F Barker; J D Almeida; J H Hoofnagle; R J Gerety; D R Jackson; P P McGrath
Journal:  J Virol       Date:  1974-12       Impact factor: 5.103

View more
  3 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  A long-term study of hepatitis B virus-related antigens and immunological parameters in children with chronic hepatitis.

Authors:  R Calzia; C Navone; B Ciravegna; R Piscopo; S Raffanti; P Tolentino
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

3.  Immunopathologic aspects of woodchuck hepatitis.

Authors:  D Frommel; D Crevat; L Vitvitsky; C Pichoud; O Hantz; M Chevalier; J A Grimaud; J Lindberg; C G Trépo
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.